Telligen Enhances Population Health Solutions with MCG Health Partnership

Share Article

Trusted partner for Federal and State agencies, health plans, and self-insured employers certifies its alliance with the industry leader in evidence-based guidance

MCG Health

MCG Health is the leader in evidence-based solutions and informed care strategies that guide health care decisions for nine of the largest U.S. health plans and over 2,000 hospitals.

“Having our Qualitrac UM solution be an MCG-certified partner helps us achieve that need for our customers.” - Brian Barry, VP of Enterprise Solutions and CIO, Telligen

Telligen is excited to announce its newly certified partnership with MCG Health, part of the Hearst Health network, after completing the integration of Telligen’s Qualitrac(TM) utilization management (UM) and prior authorization (PA) solutions with MCG’s Cite CareWebQI and Cite AutoAuth.

Telligen, having worked with MCG for more than 10 years to provide evidence-based guidelines for UM and PA clients nationwide, was eager to take this next step of certification to expand its working relationship with MCG. The enhanced value offered by this partnership helps Telligen continue its constant innovation in the ways they help clients reduce provider burden and improve health outcomes for their members.

“Telligen understands the importance of integrating sound clinical criteria in the prior authorization process for providers to receive timely and accurate decisions,” said Brian Barry, vice president of enterprise solutions and CIO at Telligen. “Having our Qualitrac UM solution be an MCG-certified partner helps us achieve that need for our customers.”

MCG President and CEO, Jon Shreve, said, “Telligen has exhibited a strong commitment to evidence-based practices, and their partnership with MCG allows us to improve delivery of effective care together through new and innovative solutions.”

Telligen’s proprietary population health management application, Qualitrac, has integrated evidence-based guidelines throughout the care coordination process thanks to MCG’s Cite CareWebQI. In addition, to help eliminate delays in care due to wait times for authorization approval, MCG Cite AutoAuth helps streamline the prior auth workflow by automatically checking PA reviews against MCG care guidelines and rendering an authorization determination in real-time.

Qualitrac’s efficient, user-friendly process combined with evidence-based content and automation software maximizes provider engagement, proactively addresses issues, and identifies potential gaps related to approval processes or clinical documentation. The integration of both systems helps support higher provider satisfaction, greater transparency, and more consistent quality performance.

About Telligen
For more than 45 years, Telligen has improved the quality and cost-effectiveness of healthcare for consumers and providers. Telligen serves commercial clients and government programs at the federal, state and local level, improving health outcomes for millions of people nationwide. For more information, visit

About MCG Health
MCG, part of the Hearst Health network, helps healthcare organizations implement informed care strategies that proactively and efficiently move people toward health. MCG’s transparent assessment of the latest research and scholarly articles, along with our own data analysis, gives patients, providers, and payers the vetted information they need to feel confident in every care decision, in every moment. For more information visit or follow our Twitter handle at @MCG_Health.

About Hearst Health
The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits and 3.2 billion dispensed prescriptions. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Arri Burgess
MCG Health
(206) 389-5405
Email >
Visit website